Investing Profile

Florent Gros

InvestorVC
Partner Health Fund II at Earlybird Venture Capital
earlybird.comAntwerp, Belgium
Photo of Florent Gros, Earlybird Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Novartis Network
53 CONNECTIONS
Novartis Network
53 CONNECTIONS
cb
$100K - $5.0M
$1.5M
21
€350m
CompanyStageDateRound SizeTotal Raised
GEMMABio
SeedDec 2024$34M
$34M
ImCheck Therapeutics
Series CJun 2022$100M
$180M
Co-investors: Klaus Breiner (Pureos Bioventures), Rémi Droller (Kurma Partners), Dr. Regina Hodits (Wellington Partners), Michael Baran (Pfizer Venture Investments), Raphael Wisniewski (Andera Partners), Vincent Brichard
Oculis
Series CMay 2021$57M
Series BJan 2018$21M
$190M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Rob Hopfner (Pivotal bioVenture Partners), Lionel Carnot (Earlybird Venture Capital), Zhi Yang (BVCF (Bioveda China Fund))
Anokion
Series BSep 2019$40M
Series AMay 2014$38M
$78M
Co-investors: Tom Woiwode (Versant Ventures), Laura Brass (MPM BioImpact), Jack Nielsen (Vivo Capital)
Binx Health
Series DJan 2017$35M
Series CJan 2015$20M
Series BApr 2014$28M
Series BJul 2011$27M
$280M
Co-investors: Matthew Rizzo (OrbiMed), Joachim Rothe (EQT Life Sciences)
Myopowers Medical Technologies
Series CJun 2015$5M
Series BJul 2011$16M
$21M
Merus
Series CApr 2015$79M
Series BOct 2013$42M
Series BJan 2010$30M
$150M
Co-investors: John de Koning (LSP), Lionel Carnot (Earlybird Venture Capital), Jack Nielsen (Vivo Capital)
Opsona
Series COct 2013$4M
Series CApr 2013$43M
Series BJun 2009$5M
$52M
Patent Attorney NestléPresent
Head IP HotmailPresent
IP Head Biologics NovartisPresent
Head IP Transactions NovartisPresent
IP Site Head NovartisPresent
Managing Director NovartisPresent
Director Captor Therapeutics SAPresent
Board Member ImCheck TherapeuticsPresent
Advisor Tavira TherapeuticsPresent
Earlybird Earlybird Venture CapitalPresent
CEO & Founder HotmailPresent
CEO & Founder Priothera SASPresent
Managing Partner HotmailPresent
Chairman & Founder Amyl TherapeuticsPresent
Partner Health Fund II Earlybird Venture CapitalPresent
Managing Director Novartis Venture Fund2001 - 2019
european patent attorney european patent attorney patent - trademark
French patent attorney French patent attorney Patent
Université de STRASBOURG Bachelor's degree Biologie (Biology)
University of Strasbourg Bachelor's degree Biologie (Biology)
Superior School of Biotechnology Master's degree Biotechnology Engineering
ESBS Master's degree Biotechnology Engineering
ESBS Master's degree Private Law
ESBS Master's degree Biotechnology Engineering
University of Mulhouse Master's degree Biotechnology Engineering
Université de STRASBOURG Master of Engineering - MEng Biotechnology
University of Lille Bachelor's degree Private Law
Université des Sciences et Technologies de Lille (Lille I) Bachelor's degree Private Law
University of Lille 1 Sciences and Technology Bachelor's degree Private Law
University of the Philippines Diliman Master's degree Private Law
University of Mulhouse Master's degree Private Law
kaufmann MBA Master of Business Administration - MBA business & Venture